KRAS and neoplasm: In support of the hypothesis that these key genes function cooperatively in driving tumorigenesis, mouse models mutated at two driver genes simultaneously have shown a synergistic increase in tumor burden, including: Pten-Apc[3], Kras-Tgfb[4], and Apc-Trp53[5].